Kemnay Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64.7K Sell
2,270
-114
-5% -$3.03K 0.01% 233
2026
Q2
$57.4K Buy
2,384
+93
+4% +$2.43K 0.01% 258
2026
Q1
$64.3K Buy
2,291
+24
+1% +$639 0.01% 201
2025
Q4
$56.4K Buy
+2,267
New +$57.2K 0.01% 290
2021
Q4
– Sell
-1,500
Closed -$65K – 67
2021
Q3
$65K Hold
1,500
– – 0.01% 81
2021
Q2
$59K Hold
1,500
– – 0.01% 87
2021
Q1
$54K Hold
1,500
– – 0.01% 82
2020
Q4
$55K Sell
1,500
-81
-5% -$2.97K 0.01% 88
2020
Q3
$55K Hold
1,581
– – 0.01% 76
2020
Q2
$49K Hold
1,581
– – 0.01% 80
2020
Q1
$49K Hold
1,581
– – 0.01% 61
2019
Q4
$59K Hold
1,581
– – 0.01% 61
2019
Q3
$54K Hold
1,581
– – 0.01% 69
2019
Q2
$65K Hold
1,581
– – 0.02% 54
2019
Q1
$64K Hold
1,581
– – 0.01% 119
2018
Q4
$65K Hold
1,581
– – 0.02% 110
2018
Q3
$66K Hold
1,581
– – 0.02% 113
2018
Q2
$54K Hold
1,581
– – 0.02% 117
2018
Q1
$53K Hold
1,581
– – 0.02% 97
2017
Q4
$54K Hold
1,581
– – 0.02% 97
2017
Q3
$54K Hold
1,581
– – 0.02% 96
2017
Q2
$50K Hold
1,581
– – 0.03% 99
2017
Q1
$51K Hold
1,581
– – 0.03% 38
2016
Q4
$49K Hold
1,581
– – 0.04% 37
2016
Q3
$51K Hold
1,581
– – 0.04% 34
2016
Q2
$53K Hold
1,581
– – 0.04% 32
2016
Q1
$44K Hold
1,581
– – 0.03% 37
2015
Q4
$48K Hold
1,581
– – 0.03% 36
2015
Q3
$47K Hold
1,581
– – 0.04% 37
2015
Q2
$50K Hold
1,581
– – 0.04% 29
2015
Q1
$52K Hold
1,581
– – 0.03% 31
2014
Q4
$47K Hold
1,581
– – 0.02% 36
2014
Q3
$44K Sell
1,581
-287,742
-99% -$8.08M 0.03% 46
2014
Q2
$8.15M Buy
289,323
+1,581
+0.5% +$45.1K 2.96% 14
2014
Q1
$8.77M Hold
287,742
– – 4.41% 9
2013
Q4
$8.36M Sell
287,742
-130,032
-31% -$3.78M 5.95% 10
2013
Q3
$11.4M Sell
417,774
-157,710
-27% -$4.29M 8.79% 3
2013
Q2
$15.3M Buy
+575,484
New +$15.9M 7.23% 6

Other funds holding PFE

Kemnay Advisory Services's PFE Position: Q3 2026 in Review

Kemnay Advisory Services reduced its Pfizer (PFE) stake by 4.8% in Q3 2026, selling an estimated $3.03K and leaving 2,270 shares worth $64.7K. The position accounts for 0.01% of the portfolio, ranked #233.

Kemnay Advisory Services first reported a position in PFE in Q2 2013 and has held it in 38 quarters since. The position peaked at $15.3M in Q2 2013. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Kemnay Advisory Services held 2,270 shares of Pfizer worth $64.7K as of Q3 2026.
  • Kemnay Advisory Services sold 114 Pfizer shares in Q3 2026, an estimated $3.03K.
  • Pfizer made up 0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #233 holding.
  • Kemnay Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 38 quarters since.
  • Kemnay Advisory Services's Pfizer position peaked at $15.3M in Q2 2013.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.